AGA Family of Websites: Gastro.org

Introducing a new CME text module, Advancing IBD Management with Precision Medicine and Emerging Data

This dynamic educational activity will deliver cutting-edge insights into the role of biomarkers in IBD.
CCO IBD Innovations 1920x1080
CCO IBD Innovations 1920x1080

AGA, in proud partnership with Clinical Care Options, LLC, and with support from an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA, invites you to explore the latest in inflammatory bowel disease (IBD) care through the innovative text module: Advancing Inflammatory Bowel Disease Management with Precision Medicine and Emerging Data

This dynamic educational activity is designed for gastroenterology professionals, including physicians, including residents and fellows, nurse practitioners, and physician associates, who are committed to staying at the forefront of IBD treatment.


Why this module matters

IBD, encompassing Crohn’s disease and ulcerative colitis, affects more than 2 million in the U.S. and presents ongoing challenges in achieving sustained remission. With the rise of treat-to-target strategies, the focus has shifted toward deep remissionbiomarker normalization, and mucosal healing—goals that demand precision and personalization in care.

This module delivers cutting-edge insights into:

  • Emerging biomarkers and diagnostics that guide individualized therapy
  • Role of biomarkers and treat-to-target approaches in IBD
  • Novel targets such as TL1A blockade with antifibrotic potential


Learning objectives

Upon completion, learners will be able to:

  • Detail available and emerging biomarkers and diagnostics informing treatment decisions in IBD
  • Incorporate biomarkers into clinical practice based on guidelines and expert consensus
  • Evaluate evidence for the utility of TL1A blockade in IBD treatment

 

Meet the faculty expert

Jordan E. Axelrad, MD, MPH, FACG
Co-Director, Inflammatory Bowel Disease Center at NYU Langone Health
Associate Professor of Medicine
NYU Grossman School of Medicine, New York, NY

Dr. Axelrad brings deep clinical expertise and research insight into the evolving IBD landscape, offering learners a practical and evidence-based perspective on precision medicine.

CME/CE Credit opportunities

Participants can earn:

  • 0.75 AMA PRA Category 1 Credit™ (Physicians)
  • 0.75 AAPA Category 1 CME credit (Physician Assistants/Associates)
  • 0.75 Nursing contact hour (Nurse Practitioners/Nurses)

 

Start learning today

Take the next step in advancing your clinical practice.

Stay in the know with AGA

Members receive our weekly newsletter, AGA eDigest, which is packed with clinical education updates, career development opportunities, member news and more.

Stay connected. Stay informed. Stay ahead.

AGA clinical guidance

Find the latest evidence-based recommendations for treating your patients.

X
American Gastroenterological Association
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.